2017 Proficiency Testing Scheme
Objectives
The principal aim of this PT was to evaluate the ability of the participating laboratories to identify the absence or presence of antibodies to capripox viruses in serum of bovine origin and/or to assess the diagnositic capability of the participating laboratories to detect capripox virus nucleic acid in samples containing material for capripox virus molecular diagnosis.
Description
Within the serology component of the PT, participants were asked to test predefined serum samples using their primary diagnostic assay(s) for serological diagnosis.
Within the virology component of the PT, participants were asked to test predefined cell culture supernatant and tissue homogenate samples using their primary diagnostic assay(s) for molecular diagnosis. Furthermore, within this component, participants could submit additional results on capripox virus species differentiation and field or vaccine strain differentiation.
Results
Participants of the 2017 PT can logon on to the extranet at the NRLs section to view the results of the 2017 Proficiency Test.